NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

急性缺血性腦中風診斷及治療的全球市場

Acute Ischemic Stroke Diagnosis and Treatment

出版商 Global Industry Analysts, Inc. 商品編碼 997609
出版日期 內容資訊 英文 185 Pages
商品交期: 最快1-2個工作天內
價格
急性缺血性腦中風診斷及治療的全球市場 Acute Ischemic Stroke Diagnosis and Treatment
出版日期: 2021年04月01日內容資訊: 英文 185 Pages
簡介

全球急性缺血性腦中風診斷及治療的市場規模,預計在分析期間(2020年∼2027年)將以4.9%的年複合成長率增長,從2020年的17億美元,到2027年達到24億美元。

本報告所分析的市場區隔之一的CT部門,在分析期間中預計將以4.2%的年複合成長率增長,達到16億美元。

本報告提供全球急性缺血性腦中風診斷及治療市場的相關調查,提供市場佔有率,Covid-19的影響,趨勢和成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

調查對象企業範例

  • Abbott Laboratories
  • Bayer AG
  • Biogen
  • Boehringer Ingelheim
  • Boston Scientific Corporation
  • Cordis Corporation
  • Covidien plc
  • Daiichi Sankyo
  • GE Healthcare
  • Genentech, Inc.
  • Hitachi Ltd
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Merck & Co., Inc.
  • Penumbra, Inc
  • Pfizer Inc.
  • Philips Healthcare
  • Sanofi
  • Siemens AG
  • Siemens Healthcare
  • Stryker Corporation

目錄

I. 調查手法

II. 摘要整理

  • 市場概要
    • 影響者市場洞察
    • 全球市場的軌跡
    • Covid-19的影響與即將到來的全球景氣衰退
  • 主要企業
  • 趨勢與推動要素
  • 全球市場預測

III. 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

IV. 競爭

  • 企業簡介:41公司

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP16120

Abstract:

Global Acute Ischemic Stroke Diagnosis and Treatment Market to Reach $2.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Acute Ischemic Stroke Diagnosis and Treatment estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$2.4 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027. Computed Tomography, one of the segments analyzed in the report, is projected to record a 4.2% CAGR and reach US$1.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Magnetic Resonance Imaging segment is readjusted to a revised 7.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $502.4 Million, While China is Forecast to Grow at 4.6% CAGR

The Acute Ischemic Stroke Diagnosis and Treatment market in the U.S. is estimated at US$502.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$421.5 Million by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 3.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.

Ultrasound Segment to Record 4% CAGR

In the global Ultrasound segment, USA, Canada, Japan, China and Europe will drive the 4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$90.8 Million in the year 2020 will reach a projected size of US$119.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$274.3 Million by the year 2027.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Bayer AG
  • Biogen
  • Boehringer Ingelheim
  • Boston Scientific Corporation
  • Cordis Corporation
  • Covidien plc
  • Daiichi Sankyo
  • GE Healthcare
  • Genentech, Inc.
  • Hitachi Ltd
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Merck & Co., Inc.
  • Penumbra, Inc
  • Pfizer Inc.
  • Philips Healthcare
  • Sanofi
  • Siemens AG
  • Siemens Healthcare
  • Stryker Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Computed Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Magnetic Resonance Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Cerebral angiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Cerebral angiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Cerebral angiography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Nuclear Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Other Diagnostic Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Other Diagnostic Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other Diagnostic Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Carotid Endarterectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Carotid Endarterectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Carotid Endarterectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Angioplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Endovascular Mechanical Thrombectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Endovascular Mechanical Thrombectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Endovascular Mechanical Thrombectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 31: USA Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2020 & 2027
    • TABLE 34: USA Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: USA 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 37: Canada Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: Canada 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2020 & 2027
    • TABLE 40: Canada Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Canada Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Canada 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 43: Japan Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Japan Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Japan 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2020 & 2027
    • TABLE 46: Japan Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Japan Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Japan 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 49: China Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: China Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: China 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2020 & 2027
    • TABLE 52: China Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: China Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: China 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 55: Europe Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 58: Europe Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Europe Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Europe 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2020 & 2027
    • TABLE 61: Europe Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Europe Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: Europe 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 64: France Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: France Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: France 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2020 & 2027
    • TABLE 67: France Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: France Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: France 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 70: Germany Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Germany Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Germany 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2020 & 2027
    • TABLE 73: Germany Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Germany Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Germany 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 76: Italy Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Italy Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Italy 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2020 & 2027
    • TABLE 79: Italy Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Italy Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: Italy 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 82: UK Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: UK Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: UK 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2020 & 2027
    • TABLE 85: UK Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: UK Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: UK 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 88: Rest of Europe Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Rest of Europe Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Rest of Europe 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2020 & 2027
    • TABLE 91: Rest of Europe Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Rest of Europe Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Rest of Europe 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 94: Asia-Pacific Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Asia-Pacific Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Asia-Pacific 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2020 & 2027
    • TABLE 97: Asia-Pacific Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Asia-Pacific Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Asia-Pacific 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 100: Rest of World Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Rest of World Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Rest of World 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2020 & 2027
    • TABLE 103: Rest of World Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Rest of World Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Rest of World 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 41